# BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

> **NCT01225822** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1973 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** BIBR 1048
- **DRUG:** BIBR 1048
- **DRUG:** BIBR 1048
- **DRUG:** BIBR 1048

## Key facts

- **NCT ID:** NCT01225822
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-08
- **Final completion:** —
- **Target enrollment:** 1973 (ACTUAL)
- **Last updated:** 2014-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225822, "BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01225822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*